Log in or Sign up for Free to view tailored content for your specialty!
Stroke News
Flu vaccination low among young adults with CVD
In 2018, about one-quarter of adults aged 18 to 34 years with CVD received a flu shot and in those with a history of MI only about 20% were vaccinated, researchers reported at the virtual American Heart Association Scientific Sessions.
The Great American Smokeout: 10 articles on quitting smoking
On the third Thursday of each November, the American Cancer Society encourages the estimated 32.4 million smokers in the United States to begin the “journey to a smoke-free life” in the “Great American Smokeout.”
Log in or Sign up for Free to view tailored content for your specialty!
SCORED/SOLOIST: Dual SGLT inhibitor shows new CV benefits in type 2 diabetes
Adults with type 2 diabetes and worsening HF or at CV risk assigned the dual SGLT1/SGLT2 inhibitor sotagliflozin saw reduced risk for CV death and hospitalization or urgent visits for HF compared with placebo.
Ticagrelor-aspirin treatment effect in THALES strongest in ipsilateral stenosis
In new data from the THALES trial of patients with prior stroke, the benefit of ticagrelor plus aspirin for secondary stroke prevention was greatest in those with ipsilateral atherosclerotic stenosis.
‘Another agent in our arsenal’: Finerenone benefits extend to those with, without CVD
Among adults with chronic kidney disease and type 2 diabetes, the mineralocorticoid receptor inhibitor antagonist finerenone reduced the incidence of CV events regardless of CVD status, according to new data from the FIDELIO trial.
Cardiac catheterizations declined during COVID-19 surge at New York center
In a single-center analysis, cardiac catheterization procedures decreased during a 6-week period of the COVID-19 lockdown compared with the same span in 2019, researchers reported.
1-year outcomes in PCI for STEMI similar in patients treated with ticagrelor vs. prasugrel
Antiplatelet therapy with ticagrelor after primary PCI for STEMI may confer similar reductions in the composite endpoint of all-cause death, MI and stroke and major bleeding compared with prasugrel, researchers reported.
AHA 2020 topics: Systemic racism, novel research, COVID-19 discussion with Fauci
Trials of novel medications and conversations on systemic racism and the ongoing COVID-19 pandemic are set to be featured at the virtual American Heart Association Scientific Sessions, which start Friday.
Low mortality, higher odds of comorbidities in hospitalized patients with stroke, OSA
Patients hospitalized with acute ischemic stroke and obstructive sleep apnea have lower in-hospital mortality compared with those without obstructive sleep apnea, but higher odds of comorbidities, researchers reported.
Stroke risk predicted by assessment score in patients with hip fractures
Results presented at the Virtual EFORT Congress showed an association between the CHA2DS2-VASc score with risk of stroke, thromboembolism and death among patients with or without atrial fibrillation undergoing treatment for hip fracture.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read